Bioscience Animal Health Past Earnings Performance
Past criteria checks 3/6
Bioscience Animal Health's earnings have been declining at an average annual rate of -0.6%, while the Healthcare industry saw earnings growing at 18.9% annually. Revenues have been growing at an average rate of 11% per year. Bioscience Animal Health's return on equity is 7.5%, and it has net margins of 2.3%.
Key information
-0.6%
Earnings growth rate
-16.3%
EPS growth rate
Healthcare Industry Growth | 23.6% |
Revenue growth rate | 11.0% |
Return on equity | 7.5% |
Net Margin | 2.3% |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Bioscience Animal Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 2,459 | 58 | 284 | 0 |
31 Dec 23 | 2,426 | 51 | 279 | 0 |
30 Sep 23 | 2,346 | 48 | 264 | 0 |
30 Jun 23 | 2,287 | 45 | 265 | 0 |
31 Mar 23 | 2,215 | 45 | 262 | 0 |
31 Dec 22 | 2,213 | 56 | 260 | 0 |
30 Sep 22 | 2,181 | 60 | 275 | 0 |
30 Jun 22 | 2,095 | 66 | 271 | 0 |
31 Mar 22 | 2,091 | 77 | 268 | 0 |
31 Dec 21 | 1,986 | 72 | 262 | 0 |
30 Sep 21 | 1,911 | 75 | 250 | 0 |
31 Dec 20 | 1,782 | 62 | 262 | 0 |
31 Dec 19 | 1,881 | 30 | 245 | 0 |
Quality Earnings: BIS-F has a high level of non-cash earnings.
Growing Profit Margin: BIS-F's current net profit margins (2.3%) are higher than last year (2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BIS-F's earnings have declined by 0.6% per year over the past 5 years.
Accelerating Growth: BIS-F's earnings growth over the past year (28.2%) exceeds its 5-year average (-0.6% per year).
Earnings vs Industry: BIS-F earnings growth over the past year (28.2%) exceeded the Healthcare industry -5.5%.
Return on Equity
High ROE: BIS-F's Return on Equity (7.5%) is considered low.